bioMérieux Business Review for the Nine Months Ended September 30, 2011

20 October, 2011

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2011.

Sales:
- Up 5.2% at constant exchange rates
- Including 4% organic growth
Robust 8% organic growth in clinical microbiology
Double-digit organic growth continues in Asia-Pacific and Latin America

Download the Complete Press Release:

Pioneering Diagnostics